Dr. Rabia (Kahveci) Sucu, MSH’s principal technical advisor for pharmaceutical policy and governance for USAID’s SAFEMed activity in Ukraine, is a medical doctor with a degree in health technology assessment (HTA) and more than 20 years of experience integrating HTA into health care reform efforts in Turkey, Ukraine, and other countries.
Prior to joining MSH, she was the director of the Health Technology Assessment Unit at Ankara Numune Training and Research Hospital in Ankara, Turkey, and a professor of family medicine at the same hospital. Dr. Sucu has contributed to numerous national and international projects around HTA, including the European Network for Health Technology Assessment and Adopting Hospital-Based Health Technology Assessment. In 2017, she served as the national clinical quality coordinator of the Turkish Ministry of Health, where she coordinated all activities involving HTA, clinical guidelines, and quality.
Dr. Sucu is the Vice President of Health Technology Assessment international (HTAi), a nonprofit organization dedicated to fostering health technology assessments worldwide, where she also serves on the board of directors. She has chaired the HTAi Developing Countries Interest Group and co-chaired the Medical Devices Interest Group. Additionally, she chaired the Euroasian HTA Initiative for six years and the Turkish Evidence Based Medicine Society for eight years. She has authored more than 150 peer-reviewed journal articles and eight books and delivered more than 300 international scientific presentations.